Clinical Trial

Multiple Ascending Dose Study of DW4421

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Multiple Ascending Dose of DW4421, phase I
Trial Details
NCT Number NCT07691242
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Healthy Adult Volunteers
Enrollment 56 participants
Start Date 2026-09
Primary Completion 2026-12 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-08